We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-14.55%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.38B
AUM Growth
-$1.44B
Cap. Flow
-$114M
Cap. Flow %
-1.78%
Top 10 Hldgs %
23.74%
Holding
150
New
4
Increased
49
Reduced
28
Closed
15

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$29.2M
2
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
+$28.5M
3
LNG icon
Cheniere Energy
LNG
+$27.5M
4
PANW icon
Palo Alto Networks
PANW
+$26.5M
5
APTV icon
Aptiv
APTV
+$24.3M

Top Sells

Rank Stock Value
1
W icon
Wayfair
W
+$63.5M
2
MGA icon
Magna International
MGA
+$61.9M
3
ASND icon
Ascendis Pharma A/S
ASND
+$48.6M
4
ASML icon
ASML
ASML
+$34.6M
5
YETI icon
Yeti Holdings
YETI
+$28M

Sector Composition

Rank Sector Weight
1 Healthcare 33.31%
2 Technology 29.3%
3 Industrials 14.62%
4 Consumer Discretionary 5.73%
5 Utilities 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRDF icon
126
Cardiff Oncology
CRDF
$66.5M
$3.64M 0.06%
1,467,922
-202,477
-12% -$716K
OM icon
127
Outset Medical
OM
$84.7M
$3.13M 0.05%
4,600
– –
SLAB icon
128
Silicon Laboratories
SLAB
$7.17B
$2.87M 0.05%
19,137
– –
CIEN icon
129
Ciena
CIEN
$53.4B
$2.61M 0.04%
43,000
-267,000
-86% -$17.5M
AIP icon
130
Arteris
AIP
$1.38B
$2.52M 0.04%
194,000
+13,741
+8% +$205K
AZTA icon
131
Azenta
AZTA
$1.3B
$2.46M 0.04%
29,700
-34,200
-54% -$2.93M
BOLT icon
132
Bolt Biotherapeutics
BOLT
$7.67M
$2.36M 0.04%
42,991
-29,484
-41% -$1.98M
ETTX
133
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$1.1M 0.02%
590,602
– –
ALLK
134
DELISTED
Allakos
ALLK
– –
-90,084
Closed -$882K
AWK icon
135
American Water Works
AWK
$26.7B
– –
-34,100
Closed -$6.44M
COMP icon
136
Compass
COMP
$8.51B
– –
-1,110,899
Closed -$10.1M
ETNB
137
DELISTED
89bio
ETNB
– –
-716,670
Closed -$9.37M
KALV
138
DELISTED
KalVista Pharmaceuticals
KALV
– –
-138,821
Closed -$1.84M
MAX icon
139
MediaAlpha
MAX
$758M
– –
-1,098,246
Closed -$17M
MGA icon
140
Magna International
MGA
$18.7B
– –
-764,400
Closed -$61.9M
NEE icon
141
NextEra Energy
NEE
$181B
– –
-47,900
Closed -$4.47M
PL icon
142
Planet Labs
PL
$7.3B
– –
-155,000
Closed -$953K
PLRX icon
143
Pliant Therapeutics
PLRX
$64.4M
– –
-42,499
Closed -$574K
SBAC icon
144
SBA Communications
SBAC
$19.2B
– –
-13,200
Closed -$5.13M
W icon
145
Wayfair
W
$11.2B
– –
-334,477
Closed -$63.5M
AQNU
146
DELISTED
Algonquin Power & Utilities Corp Units
AQNU
– –
-140,800
Closed -$6.65M
SBNY
147
DELISTED
Signature Bank
SBNY
– –
-48,750
Closed -$15.8M
2 3 4 5
6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Eventide Asset Management held 150 positions worth $6.38B, down 18% from $7.83B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q1 2022 filing shows 4 new, 49 increased, 28 reduced and 15 closed positions. Its largest new stake was Walker & Dunlop: 121,935 shares worth $15.8M. The largest sale was Wayfair, an estimated $63.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2022 buy was Walker & Dunlop: 121,935 shares worth $15.8M.
  • Eventide Asset Management added most to Guardant Health in Q1 2022, an estimated $29.2M increase.
  • Eventide Asset Management's biggest Q1 2022 reduction was Ascendis Pharma A/S, cutting an estimated $48.6M.
  • Eventide Asset Management fully exited Wayfair in Q1 2022, selling an estimated $63.5M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.38B portfolio in Q1 2022.
  • Eventide Asset Management opened 4 new positions and closed 15 in Q1 2022.
  • Eventide Asset Management's portfolio value fell 18% quarter-over-quarter to $6.38B.

Based on Eventide Asset Management's 13F filing for Q1 2022, filed 16 May 2022.